DOYLESTOWN, Pa., Aug. 12, 2019 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $1.7 million for the three months ended June 30, 2019.
DOYLESTOWN, Pennsylvania, May 12, 2020 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced net sales of $1.9 million for the three months ended March.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
DOYLESTOWN, Pennsylvania, Nov. 12, 2019 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.8 million for the three months ended.
A look at the shareholders of ProPhase Labs, Inc. (NASDAQ:PRPH) can tell us which group is most powerful. Generally...
Anyone interested in ProPhase Labs, Inc. (NASDAQ:PRPH) should probably be aware that the Chairman & CEO, Ted Karkus...
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...
DOYLESTOWN, Pennsylvania, March 25, 2020 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced its net sales were $9.9 million for the year ended December.
Ted Karkus has been the CEO of ProPhase Labs, Inc. (NASDAQ:PRPH) since 2009. First, this article will compare CEO...
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter dietary supplements (“ProPhase” or “Company”), announced today that its Board of Directors has declared a special cash dividend in the amount of $0.25 per share on its common stock, payable on December 12, 2019 to stockholders of record as of December 3, 2019. In connection with the special cash dividend, the Compensation Committee of the Board of Directors has approved a proportionate and equitable adjustment to the stock option granted to Mr. Karkus on February 23, 2018, as required under the 2018 Stock Incentive Plan, subject to the vesting requirements of the stock option.
Ted Karkus has been the CEO of ProPhase Labs, Inc. (NASDAQ:PRPH) since 2009. This report will, first, examine the CEO...
Monday's massive swoon quickly sent that record into the ash heap of history, as the Dow fell by 2,013 points, or 7.8%, to 23,851, as the continued spread of coronavirus and a potential crude oil price war triggered a required 15-minute halt to trading just four minutes after the market opened. Plymouth Meeting-based Inovio Pharmaceuticals (NASDAQ: INO) had been virtually the region’s sole winner over the past week, as its stock was on a steady ascent since announcing it was accelerating the development of its experimental coronavirus vaccine INO-4800. Wilmington-based chemical manufacturer Chemours Co. (NYSE: CC) fell by 22.8% to $10.40.